Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2013Molecular Nutrition & Food ResearchOpen Access

Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLeeCole LegetteOregon State UniversityCKChanida KarnprachaOregon State UniversityRRRalph L. ReedOregon State University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Legette et al. (2013) studied this question.

synapsesocial.com/papers/6aa93c26f486d0383d255503https://doi.org/10.1002/mnfr.201300333
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activation of Proestrogens from Hops (<i>Humulus lupulus </i>L.) by Intestinal Microbiota; Conversion of Isoxanthohumol into 8-Prenylnaringenin2005 · 180 citations
  2. 2Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic2012 · 103 citations
  3. 3Xanthohumol and Related Prenylated Flavonoids Inhibit Inflammatory Cytokine Production in LPS-Activated THP-1 Monocytes: Structure-Activity Relationships andIn SilicoBinding to Myeloid Differentiation Protein-2 (MD-2)2010 · 93 citations
  4. 4Xanthohumol from Hop (Humulus lupulus L.) Is an Efficient Inhibitor of Monocyte Chemoattractant Protein-1 and Tumor Necrosis Factor-α Release in LPS-Stimulated RAW 264.7 Mouse Macrophages and U937 Human Monocytes2009 · 60 citations
  5. 5Applied Biopharmaceutics and Pharmacokinetics.1981 · 1,206 citations